Hedge Fund - Broadwood Capital
Lineage Cell Therapeutics Inc. (LCTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $22,381,744 | 1.81% | 49,560,992 | $0.59 |
| 2 | 2024 - Q4 (2024-12-31) | $20,937,293 | 1.63% | 41,666,255 | $0.73 |
| 3 | 2024 - Q3 (2024-09-30) | $37,720,461 | 2.89% | 41,666,255 | $0.93 |
| 4 | 2024 - Q2 (2024-06-30) | $41,553,756 | 3.14% | 41,666,255 | $1.10 |
| 5 | 2024 - Q1 (2024-03-31) | $61,666,057 | 4.63% | 41,666,255 | $1.13 |
| 6 | 2023 - Q4 (2023-12-31) | $38,079,679 | 3.24% | 34,935,485 | $1.10 |
| 7 | 2023 - Q3 (2023-09-30) | $41,223,872 | 3.66% | 34,935,485 | $1.36 |
| 8 | 2023 - Q2 (2023-06-30) | $49,259,034 | 3.68% | 34,935,485 | $1.38 |
| 9 | 2023 - Q1 (2023-03-31) | $52,403,228 | 3.68% | 34,935,485 | $1.40 |
| 10 | 2022 - Q4 (2022-12-31) | $40,874,517 | 3.41% | 34,935,485 | $1.26 |
| 11 | 2022 - Q3 (2022-09-30) | $39,477,000 | 3.01% | 34,935,485 | $1.47 |
| 12 | 2022 - Q2 (2022-06-30) | $55,198,000 | 4.16% | 34,935,485 | $1.32 |
| 13 | 2022 - Q1 (2022-03-31) | $53,801,000 | 3.87% | 34,935,485 | $1.55 |
| 14 | 2021 - Q4 (2021-12-31) | $83,313,000 | 5.11% | 34,005,379 | $2.34 |
| 15 | 2021 - Q3 (2021-09-30) | $85,694,000 | 4.36% | 34,005,379 | $2.57 |
| 16 | 2021 - Q2 (2021-06-30) | $96,915,000 | 4.33% | 34,005,379 | $2.59 |
| 17 | 2021 - Q1 (2021-03-31) | $79,913,000 | 4.24% | 34,005,379 | $2.40 |
| 18 | 2020 - Q4 (2020-12-31) | $59,849,000 | 3.55% | 34,005,379 | $1.40 |
| 19 | 2020 - Q3 (2020-09-30) | $31,849,000 | 2.5% | 34,005,379 | $0.88 |
| 20 | 2020 - Q2 (2020-06-30) | $29,585,000 | 2.31% | 34,005,379 | $0.88 |
| 21 | 2020 - Q1 (2020-03-31) | $28,160,000 | 3.29% | 34,005,379 | $1.00 |
| 22 | 2019 - Q4 (2019-12-31) | $30,265,000 | 3.48% | 34,005,379 | $0.83 |
| 23 | 2019 - Q3 (2019-09-30) | $33,325,000 | 4.62% | 34,005,379 | $1.04 |
The displayed share prices are average quarterly stock market prices.